PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10311102

Program evaluation in terminal care.

D M Dush·B R Cassileth
View original source ↗Export metadata ↓

Abstract

The expansion of hospice care brings new challenges for accountability, program evaluation, and research. The present paper attempts to examine (a) the various goals, tasks, and conceptual models of program evaluation relevant to terminal care, and (b) the applicability of two illustrative evaluation strategies: experimental designs and time-series analysis.

Explore related subjects

Cost-Benefit AnalysisEvaluation Studies as TopicHospicesManagement AuditOutcome and Process Assessment, Health CareUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D M Dush, B R Cassileth. 1985. Program evaluation in terminal care.. https://doi.org/10.1080/0742-969x.1985.11882519

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Low-cost on-the-job peer training of nurses improved immunization coverage in Indonesia.

In Indonesia responsibility for immunizations is placed on local government health centres and on the nurses who provide the immunizations at each centre. An on-the-job peer training programme for these nurses, which was designed to improve the immunization performance of poorly performing health centres in terms of coverage and practice in Maluku province, was evaluated. Experienced immunization nurses were sent to health centres where nurses were inexperienced or performing poorly; the experienced nurses spent 1-2 weeks providing on-the-job training for the less experienced ones. An evaluation of the 13 centres that participated in the programme and the 95 that did not found that the programme increased both immunization coverage and the quality of practice. Coverage of diphtheria/pertussis/tetanus (DPT), polio, and measles vaccinations rose by about 39% in all 13 participating centres when compared with non-participating centres, and by about 54% in the 11 centres that had a functioning transportation system during the year after training. These results reflect increases in the actual number of doses given and improvements in the accuracy of reports. Potential threats to the study's validity were examined and found not to be significant. The out-of-pocket cost of the training programme was about US$ 53 per trainee or about US$ 0.05 per additional vaccine reported to have been given. The marginal cost per additional fully immunized child was estimated to be US$ 0.50.

Cost-Benefit Analysis↗
PubMed2001

Lung cancer screening: an update.

Two prominent and timely issues in lung cancer screening are discussed in this article. First, findings from extended mortality follow-up of participants enrolled as part of the Mayo Lung Project are reviewed. These findings suggest that overdiagnosis-the identification, through screening, of clinically unimportant lung cancer lesions-may occur when screening for lung cancer. Second, the question of whether sufficient evidence exists to advocate mass lung cancer screening with low radiation dose spiral computed tomography (CT) is discussed. Given the absence of lung cancer mortality data for spiral CT, it is concluded that such activities should not be advocated at this point in time. The Lung Screening Study, an ongoing randomized controlled trial of lung cancer screening with spiral CT, also is described.

Cost-Benefit Analysis↗